Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$432.60 -0.19 (-0.04%)
At close: Nov 10, 2026 · 4:00 PM EST

Madrigal Pharmaceuticals (MDGL) Non Operating Interest Expenses (2009 - 2026)

Updated

Madrigal Pharmaceuticals' Non Operating Interest Expenses came in at $8.1 million for Q3 2026, up 8.0% from $7.5 million a year earlier and up 2.0% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Madrigal Pharmaceuticals reported Non Operating Interest Expenses of $32.16 million, up 82.7% year-over-year; for FY2025, it came in at $22.31 million, up 52.1% from FY2024.

  • Non Operating Interest Expenses has increased in each of the last three years, with a three-year compound annual growth rate of 77.9% (FY2022 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $14.67 million in FY2024 (+15.4%), $12.71 million in FY2023 (+220.7%) and $3.96 million in FY2022.
  • The five-year range for quarterly Non Operating Interest Expenses is $780,000 (Q2 2022) to $8.3 million (Q4 2025).
  • Year-over-year, Non Operating Interest Expenses has increased for five consecutive quarters, with growth averaging 61.4% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q2 2023 (growth of 271.9%), and the weakest in Q1 2025 (a decline of 14.0%).
  • Business Quant data shows MDGL's Non Operating Interest Expenses at $7.94 million (Q2 2026), $7.82 million (Q1 2026) and $8.3 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Madrigal Pharmaceuticals 12.65 Bn 9.06 Bn 393.45 Mn 8.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.10 Mn
Jun 30, 2026 7.94 Mn
Mar 31, 2026 7.82 Mn
Dec 31, 2025 8.30 Mn
Sep 30, 2025 7.50 Mn
Jun 30, 2025 3.30 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 3.50 Mn
Sep 30, 2024 3.68 Mn
Jun 30, 2024 3.66 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 3.97 Mn
Sep 30, 2023 3.50 Mn
Jun 30, 2023 2.90 Mn
Mar 31, 2023 2.34 Mn
Dec 31, 2022 1.68 Mn
Sep 30, 2022 1.50 Mn
Jun 30, 2022 780,000.00
Dec 31, 2018 -8.45 Mn
Sep 30, 2018 -8.36 Mn
API Access

Madrigal Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEY